Investigators from Stanford University Zero in on Heart Disease (Sglt2 Inhibitor Ameliorates Endothelial Dysfunction Associated With the Common Aldh2 Alcohol Flushing Variant)

Press/Media

PeriodMar 24 2023

Media coverage

1

Media coverage

  • TitleInvestigators from Stanford University Zero in on Heart Disease (Sglt2 Inhibitor Ameliorates Endothelial Dysfunction Associated With the Common Aldh2 Alcohol Flushing Variant)
    Media name/outletHeart Disease Daily
    Country/TerritoryUnited States
    Date03/24/23
    PersonsYu Sunny Liu
View all 1
View less